Barely Significant

Excerpts

5,102 sentences · 1 filter applied

showed a trendp = 0.081.6× alpha
♀ 11.5 ± 5.2, p < 0.001) and SB showed a trend of being higher in males (♂4.4 ± 1.2 vs. ♀ 2.8 ± 0.84, p = 0.08); and for severe OSA, all questionnaires, apart from SB, were found to be higher in females (ESS: ♂ 9.5 ± 4.7 vs. ♀ 10.8 ± 4.7, p = 0.03; BQ: x 2 = 17.2, p = 0.001; AIS: ♂ 7.8 ± 5 vs. ♀ 10.2 ± 5.8, p = 0.05; STOP: ♂ 2.4 ± 0.84 vs. ♀ 2.83 ± 0.8, p < 0.001; FS: x 2 = 5.26, p = 0.02).
an increasing trendp = 0.081.6× alphagold
However, plasma levels of Aβ 1-42 , t-Tau, and p-Tau181 showed an increasing trend in patients exhibiting a decrease in cognitive function (Aβ 1-42 : r = −0.832, p = 0.08; t-Tau: r = −0.932, p < 0.05; p-Tau181: r = −0.703, p = 0.185; Figure 2 b–d).
marginal significancep = 0.0801.6× alphagold
In the case of normalized ESR or CRP at 3 months, patients with normalized ESR or CRP at 3 months showed only a marginal significance in ASDAS-ID achievement (ESR, OR = 2.04; CI, 0.92–4.55; p = 0.080 and CRP, OR = 2.03; CI, 0.97–4.27; p = 0.060) ( Figure 3 A,C) but showed a significant difference in BASDAI-CRP attainment (ESR, OR = 3.29; CI, 1.42–7.46; p = 0.004 and CRP, OR = 2.73; CI, 1.32–5.62; p = 0.007), especially at 3 and 9 months (ESR: 3 months, p = 0.005; 9 months, p = 0.015 and CRP: 3 months, p < 0.001; 9 months, p = 0.021) ( Figure 3 B,D). 4.
showed a trendp = 0.081.6× alpha
There was a significant increase in aldosterone and renin concentrations following a 120 min period of an upright posture (i.e., standing or sitting position), p < 0.0001; however, an overall suppression of aldosterone secretion was either not different after the first protocol versus the second protocol (6.34 ± 0.68 ng/dL (mean ± SEM) versus 5.74 ± 0.66 ng/dL, p = 0.124 (Mann–Whitney U test)) or showed a trend towards slightly lower values ( p = 0.08 for Wilcoxon test (mean ± SEM)).
a statistical trendp = 0.081.6× alphagold
In this survey, these features were associated with higher proportions of respondents assigning the top rating for “confidence in correct use”—from 52% to 64% among patients ( p = 0.08, indicating a statistical trend), 23% to 49% among GPs ( p < 0.001), and 46% to 58% among specialists ( p < 0.05).